Reports from Regeneron Pharmaceuticals Inc. Provide New Insights into COVID-19 (Effectiveness of Casirivimab and Imdevimab Antibody Combination In Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: a Post Hoc Analysis In a ...)

  • Meagan P. O'Brien

Press/Media

Period23 Jun 2023

Media coverage

1

Media coverage

  • TitleReports from Regeneron Pharmaceuticals Inc. Provide New Insights into COVID-19 (Effectiveness of Casirivimab and Imdevimab Antibody Combination In Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: a Post Hoc Analysis In a ...)
    Media name/outletNewsRx COVID-19 Daily
    Country/TerritoryUnited States
    Date23/06/23
    URLct.moreover.com/?a=51131535372&p=1gw&v=1&x=6Zh_4tf6IOmHJWtQUB3s9A
    PersonsMeagan P. O'Brien